Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer

Abstract

Molecular mechanisms of prostate cancer progression are poorly understood. Here, we studied gene amplification of the large conductance calcium-activated potassium channel alpha subunit (KCNMA1), which is located at the chromosomal region 10q22. Fluorescence in situ hybridization (FISH) revealed KCNMA1 amplification in 16% of 119 late-stage human prostate cancers and in the hormone-insensitive prostate cancer cell line PC-3. In contrast, KCNMA1 amplification was absent in 33 benign controls, 32 precursor lesions and in 105 clinically organ-confined prostate cancers. Amplification was associated with mRNA and protein overexpression as well as increased density of BK channel protein and β-estradiol-insensitive BK currents in PC-3 cells as compared to non-amplified control cell lines. Specific blockade of BK channels by iberiotoxin or RNAi significantly inhibited K+ currents and growth of PC-3 cells. The data demonstrate that 10q22 amplification drives KCNMA1 expression and cell proliferation. Thus, KCNMA1 qualifies as a promising diagnostic and therapeutic target in patients with prostate cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Albertson DG, Collins C, McCormick F, Gray JW . (2003). Chromosome aberrations in solid tumors. Nat Genet 34: 369–376.

    Article  CAS  PubMed  Google Scholar 

  • Amberg GC, Bonev AD, Rossow CF, Nelson MT, Santana LF . (2003). Modulation of the molecular composition of large conductance, Ca(2+) activated K(+) channels in vascular smooth muscle during hypertension. J Clin Invest 112: 717–724.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Amberg GC, Santana LF . (2003). Downregulation of the BK channel beta1 subunit in genetic hypertension. Circ Res 93: 965–971.

    Article  CAS  PubMed  Google Scholar 

  • Basrai D, Kraft R, Bollensdorff C, Liebmann L, Benndorf K, Patt S . (2002). BK channel blockers inhibit potassium-induced proliferation of human astrocytoma cells. Neuroreport 13: 403–407.

    Article  CAS  PubMed  Google Scholar 

  • Bernardino J, Bourgeois CA, Muleris M, Dutrillaux AM, Malfoy B, Dutrillaux B . (1997). Characterization of chromosome changes in two human prostatic carcinoma cell lines (PC-3 and DU145) using chromosome painting and comparative genomic hybridization. Cancer Genet Cytogenet 96: 123–128.

    Article  CAS  PubMed  Google Scholar 

  • Calderone V . (2002). Large-conductance, Ca(2+)-activated K(+) channels: function, pharmacology and drugs. Curr Med Chem 9: 1385–1395.

    Article  CAS  PubMed  Google Scholar 

  • Christow SP, Bychkov R, Schroeder C, Dietz R, Haller H, Dumler I et al. (1999). Urokinase activates calcium-dependent potassium channels in U937 cells via calcium release from intracellular stores. Eur J Biochem 265: 264–272.

    Article  CAS  PubMed  Google Scholar 

  • Coiret G, Matifat F, Hague F, Ouadid-Ahidouch H . (2005). 17-Beta-estradiol activates maxi-K channels through a non-genomic pathway in human breast cancer cells. FEBS Lett 579: 2995–3000.

    Article  CAS  PubMed  Google Scholar 

  • Conti M . (2004). Targeting K+ channels for cancer therapy. J Exp Ther Oncol 4: 161–166.

    CAS  PubMed  Google Scholar 

  • Davies AG, Pierce-Shimomura JT, Kim H, VanHoven MK, Thiele TR, Bonci A et al. (2003). A central role of the BK potassium channel in behavioral responses to ethanol in C. elegans. Cell 115: 655–666.

    Article  CAS  PubMed  Google Scholar 

  • El Gedaily A, Bubendorf L, Willi N, Fu W, Richter J, Moch H et al. (2001). Discovery of new amplification loci in prostate cancer by comparative genomic hybridization. Prostate 46: 184–190.

    Article  CAS  PubMed  Google Scholar 

  • Galvez A, Gimenez-Gallego G, Reuben JP, Roy-Contancin L, Feigenbaum P, Kaczorowski GJ et al. (1990). Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem 265: 11083–11090.

    CAS  PubMed  Google Scholar 

  • Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan P . (1995). Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In vitro Cell Dev Biol Anim 31: 14–24.

    Article  CAS  PubMed  Google Scholar 

  • Helenius MA, Saramaki OR, Linja MJ, Tammela TL, Visakorpi T . (2001). Amplification of urokinase gene in prostate cancer. Cancer Res 61: 5340–5344.

    CAS  PubMed  Google Scholar 

  • Helenius MA, Savinainen KJ, Bova GS, Visakorpi T . (2006). Amplification of the urokinase gene and the sensitivity of prostate cancer cells to urokinase inhibitors. BJU Int 97: 404–409.

    Article  CAS  PubMed  Google Scholar 

  • Henke G, Maier G, Wallisch S, Boehmer C, Lang F . (2004). Regulation of the voltage gated K+ channel Kv1.3 by the ubiquitin ligase Nedd4-2 and the serum and glucocorticoid inducible kinase SGK1. J Cell Physiol 199: 194–199.

    Article  CAS  PubMed  Google Scholar 

  • Ho SM . (2004). Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates. J Cell Biochem 91: 491–503.

    Article  CAS  PubMed  Google Scholar 

  • Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L et al. (1980). The LNCaP cell line – a new model for studies on human prostatic carcinoma. Prog Clin Biol Res 37: 115–132.

    CAS  PubMed  Google Scholar 

  • Hsing AW, Tsao L, Devesa SS . (2000). International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85: 60–67.

    Article  CAS  PubMed  Google Scholar 

  • Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW . (1979). Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 17: 16–23.

    CAS  PubMed  Google Scholar 

  • Kauraniemi P, Barlund M, Monni O, Kallioniemi A . (2001). New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61: 8235–8240.

    CAS  PubMed  Google Scholar 

  • Knuutila S, Autio K, Aalto Y . (2000). Online access to CGH data of DNA sequence copy number changes. Am J Pathol 157: 689.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S et al. (1998). Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 4: 844–847.

    Article  CAS  PubMed  Google Scholar 

  • Koochekpour S, Zhuang YJ, Beroukhim R, Hsieh CL, Hofer MD, Zhau HE et al. (2005). Amplification and overexpression of prosaposin in prostate cancer. Genes Chromosomes Cancer 44: 351–364.

    Article  CAS  PubMed  Google Scholar 

  • Kunzelmann K, Mall M . (2002). Electrolyte transport in the mammalian colon: mechanisms and implications for disease. Physiol Rev 82: 245–289.

    Article  CAS  PubMed  Google Scholar 

  • Lau KM, LaSpina M, Long J, Ho SM . (2000). Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res 60: 3175–3182.

    CAS  PubMed  Google Scholar 

  • McCobb DP, Fowler NL, Featherstone T, Lingle CJ, Saito M, Krause JE et al. (1995). A human calcium-activated potassium channel gene expressed in vascular smooth muscle. Am J Physiol 269: H767–H777.

    CAS  PubMed  Google Scholar 

  • O’Grady SM, Lee SY . (2005). Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int J Biochem Cell Biol 37: 1578–1594.

    Article  PubMed  Google Scholar 

  • Olsen ML, Weaver AK, Ritch PS, Sontheimer H . (2005). Modulation of glioma BK channels via erbB2. J Neurosci Res 81: 179–189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • O’Malley D, Harvey J . (2004). Insulin activates native and recombinant large conductance Ca(2+)-activated potassium channels via a mitogen-activated protein kinase-dependent process. Mol Pharmacol 65: 1352–1363.

    Article  PubMed  Google Scholar 

  • Orio P, Rojas P, Ferreira G, Latorre R . (2002). New disguises for an old channel: MaxiK channel beta-subunits. News Physiol Sci 17: 156–161.

    CAS  PubMed  Google Scholar 

  • Pardo LA . (2004). Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 19: 285–292.

    CAS  Google Scholar 

  • Pardo LA, del Camino D, Sanchez A, Alves F, Bruggemann A, Beckh S et al. (1999). Oncogenic potential of EAG K(+) channels. EMBOJ 18: 5540–5547.

    Article  CAS  Google Scholar 

  • Parihar AS, Coghlan MJ, Gopalakrishnan M, Shieh CC . (2003). Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol 471: 157–164.

    Article  CAS  PubMed  Google Scholar 

  • Pei L, Wiser O, Slavin A, Mu D, Powers S, Jan LY et al. (2003). Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci USA 100: 7803–7807.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petrylak DP, Tangen CM, Hussain MH, Lara Jr PN, Jones JA, Taplin ME et al. (2004). Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351: 1513–1520.

    Article  CAS  PubMed  Google Scholar 

  • Quirk JC, Reinhart PH . (2001). Identification of a novel tetramerization domain in large conductance K(ca) channels. Neuron 32: 13–23.

    Article  CAS  PubMed  Google Scholar 

  • Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D . (1997). GeneCards: integrating information about genes, proteins and diseases. Trends Genet 13: 163.

    Article  CAS  PubMed  Google Scholar 

  • Reiter RE, Sato I, Thomas G, Qian J, Gu Z, Watabe T et al. (2000). Coamplification of prostate stem cell antigen (PSCA) and MYC in locally advanced prostate cancer. Genes Chromosomes Cancer 27: 95–103.

    Article  CAS  PubMed  Google Scholar 

  • Robitaille R, Charlton MP . (1992). Presynaptic calcium signals and transmitter release are modulated by calcium-activated potassium channels. J Neurosci 12: 297–305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sausbier M, Matos JE, Sausbier U, Beranek G, Arntz C, Neuhuber W et al. (2006). Distal colonic K(+) secretion occurs via BK channels. J Am Soc Nephrol 17: 1275–1282.

    Article  CAS  PubMed  Google Scholar 

  • Tseng-Crank J, Foster CD, Krause JD, Mertz R, Godinot N, DiChiara TJ et al. (1994). Cloning, expression, and distribution of functionally distinct Ca(2+)-activated K+ channel isoforms from human brain. Neuron 13: 1315–1330.

    Article  CAS  PubMed  Google Scholar 

  • Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI et al. (1999). Acute activation of Maxi-K channels (hSlo) by estradiol binding to the beta subunit. Science 285: 1929–1931.

    Article  CAS  PubMed  Google Scholar 

  • Van Coppenolle F, Skryma R, Ouadid-Ahidouch H, Slomianny C, Roudbaraki M, Delcourt P et al. (2004). Prolactin stimulates cell proliferation through a long form of prolactin receptor and K+ channel activation. Biochem J 377: 569–578.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, Trapman J et al. (1992). The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41: 665–669.

    Article  CAS  PubMed  Google Scholar 

  • Wang Z . (2004). Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch 448: 274–286.

    Article  CAS  PubMed  Google Scholar 

  • Weaver AK, Liu X, Sontheimer H . (2004). Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 78: 224–234.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhou XB, Wang GX, Ruth P, Huneke B, Korth M . (2000). BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 279: C1751–C1759.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful to Martina Mirlacher, Alex Rufle Hedvika Novotny, Ursula Dürrmüller and Dr Heide Tullberg from the Institute for Pathology, University Hospital Basel, and Dr Rainer Schreiber, Professor Dr Richard Warth and Melanie Spitzner at the University of Regensburg for their expert technical advice. We also thank Professor Dr Peter Ruth, Dr Matthias Sausbier and Ulrike Sausbier from the Institute of Pharmacy, University of Tübingen, Germany for generously providing the BK channel antibody.

The PC-3 cell line was kindly provided by Spyro Mousses, PhD (Translational Genomics Research Institute, Gaithersburg, MD, USA), LNCaP was from Meera Srivastava, PhD (Uniformed Services University of the Health Sciences, Bethesda, MD, USA) and BPH-1 was from Holger Rumpold, MD (Institute for Biomedical Ageing, Innsbruck, Austria).

This study was supported by the Stammbach Foundation/SWISS BRIDGE (KLS 01114-02-2001), by the Swiss National Science Foundation (Grant No. 3100A0-105413) and by the Deutsche Forschungsgemeinschaft DFG SCHR 752/2-1.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L Bubendorf.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bloch, M., Ousingsawat, J., Simon, R. et al. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene 26, 2525–2534 (2007). https://doi.org/10.1038/sj.onc.1210036

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210036

Keywords

This article is cited by

Search

Quick links